Smith Susan Laura
Insider CIK 1901039 · YMAB SVP & CHIEF COMMERCIAL OFFICER
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2024-03-05 | 2024-03-07 | 1,682 | $16.55 | $27.8K | 33,918 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2024-01-18 | 2024-01-22 | 35,700 | — | $0 | 35,700 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2024-01-18 | 2024-01-22 | 17,800 | — | $0 | 35,600 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2023-01-26 | 2023-01-30 | 32,000 | — | $0 | 32,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2023-01-17 | 2023-01-19 | 35,700 | — | $0 | 35,700 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2023-01-17 | 2023-01-19 | 17,800 | — | $0 | 17,800 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2022-04-26 | 2022-04-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2021-12-14 | 2021-12-23 | 64,000 | — | $0 | 64,000 | SEC↗ |